George Cornett, MD
Internal Medicine · Franklin, INNPI 1902808199
Payments from drug & device makers
Across 871 payments — averaging $1535.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$659K
- Novo Nordisk AS$332K
- AbbVie$165K
- AstraZeneca$42K
- Alnylam Pharmaceuticals Inc.$40K
- Astrazeneca UK Limited$21K
- plus $79K from 28 others
Across 26 payments — averaging $2918.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$74K
- GSK$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 53 | $659,134 |
| Novo Nordisk AS | 498 | $331,560 |
| AbbVie | 79 | $164,898 |
| AstraZeneca | 10 | $41,714 |
| Alnylam Pharmaceuticals Inc. | 105 | $40,111 |
| Astrazeneca UK Limited | 2 | $21,495 |
| GSK | 17 | $18,607 |
| Pfizer | 14 | $17,416 |
| Urovant Sciences Inc | 5 | $11,974 |
| Sumitomo Pharma America, Inc. | 12 | $11,513 |
| Boehringer Ingelheim | 5 | $7,263 |
| Sanofi US Services Inc. | 2 | $6,109 |
| Sanofi-aventis U.S. LLC | 3 | $3,404 |
| Boehringer Ingelheim International GmbH | 9 | $767 |
| Merck | 6 | $706 |
| Novo Nordisk | 16 | $190 |
| Exact Sciences | 6 | $108 |
| Sanofi | 5 | $90 |
| Abbott | 5 | $84 |
| Astellas Pharma US Inc | 3 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Sanofi Pasteur Inc. | 1 | $28 |
| Johnson & Johnson | 2 | $24 |
| Nalpropion Pharmaceuticals LLC | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Medtronic | 1 | $15 |
| Organon | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Biogen | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,337,429 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Franklin
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
- Allon FriedmanIndianapolis$524K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.